Insider Selling: Vita Life Sciences Limited (ASX:VLS) Insider Sells A$654,000.00 in Stock

Vita Life Sciences Limited (ASX:VLSGet Free Report) insider Henry Townsing sold 300,000 shares of the stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of A$2.18 ($1.44), for a total transaction of A$654,000.00 ($433,112.58).

Henry Townsing also recently made the following trade(s):

  • On Friday, April 12th, Henry Townsing sold 100,000 shares of Vita Life Sciences stock. The stock was sold at an average price of A$2.10 ($1.39), for a total transaction of A$210,000.00 ($139,072.85).
  • On Wednesday, March 27th, Henry Townsing 300,000 shares of Vita Life Sciences stock.

Vita Life Sciences Price Performance

The company has a debt-to-equity ratio of 0.89, a current ratio of 2.98 and a quick ratio of 1.57.

Vita Life Sciences Increases Dividend

The company also recently disclosed a Final dividend, which was paid on Thursday, April 11th. Shareholders of record on Thursday, April 11th were issued a $0.06 dividend. This is a boost from Vita Life Sciences’s previous Final dividend of $0.03. The ex-dividend date was Thursday, March 21st. This represents a yield of 2.6%. Vita Life Sciences’s payout ratio is presently 52.94%.

About Vita Life Sciences

(Get Free Report)

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritionals; urinary health; weight management; immunity; skin, hair, and nails; liver and digestion; fertility, pregnancy, and postpartum; blood sugar management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidants; bones, joints, and muscles; and eye health.

Featured Articles

Receive News & Ratings for Vita Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vita Life Sciences and related companies with's FREE daily email newsletter.